The American Diabetes Association will prioritize translational applications that move knowledge and discovery gained from basic research to its eventual translation into patient and population benefit. The ideal applicant will propose innovative research that will be an important step towards the eventual goal of improving the lives of people at risk of diabetes or living with the disease - and the pathway to this impact is clear.
ADA will accept up to two (2) nominations per institution with one (1) nomination spanning basic through preclinical research and one (1) nomination spanning clinical through public health research. The ADA offers two funding mechanisms: the Accelerator Award and the Initiator Award. Applicants must meet the eligibility criteria outlined in the RFA to apply for either mechanism.
Interested applications should submit pre-proposals following the Limited Submission Pre-Proposal Instructions electronically to the application system by Friday, June 13, 2025, at 11:59PM ET. Questions should be directed to Katelyn Still at kastill@wakehealth.edu.
Deadlines:
- Internal Deadline: June 13, 2025, at 11:59 pm ET
- Selection of Applicants: Monday, June 30th
- External Deadline: Wednesday, July 23, 2025